APA (7th ed.) Citation

Sachpekidis, C., Dimitrakopoulou-Strauss, A., Delorme, S., & Goldschmidt, H. (2017). Functional imaging with 18F-FDG PET/CT and diffusion weighted imaging (DWI) in early response evaluation of combination therapy of elotuzumab, lenalidomide, and dexamethasone in a relapsed multiple myeloma patient. Diagnostics, 7(4), . https://doi.org/10.3390/diagnostics7040061

Chicago Style (17th ed.) Citation

Sachpekidis, Christos, Antonia Dimitrakopoulou-Strauss, Stefan Delorme, and Hartmut Goldschmidt. "Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient." Diagnostics 7, no. 4 (2017). https://doi.org/10.3390/diagnostics7040061.

MLA (9th ed.) Citation

Sachpekidis, Christos, et al. "Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient." Diagnostics, vol. 7, no. 4, 2017, https://doi.org/10.3390/diagnostics7040061.